Reported Pregnancy Outcomes after Biologic Therapy Exposure in Hidradenitis Suppurativa: A Systematic Review of Published Cases

Authors

  • Verónica Sánchez-García Dermatology Department, General University Hospital of Elche, Foundation for the Promotion of Health and Biomedical Research of the Valencia Region (FISABIO), Alicante, Spain; Clinical Medicine Department, Miguel Hernández University, Alicante, Spain https://orcid.org/0000-0001-6680-9716
  • Eva de-Miguel-Balsa Clinical Medicine Department, Miguel Hernández University, Alicante, Spain https://orcid.org/0000-0002-2117-7257
  • José-Manuel Ramos-Rincón Clinical Medicine Department, Miguel Hernández University, Alicante, Spain https://orcid.org/0000-0002-6501-9867
  • Isabel Belinchón-Romero Clinical Medicine Department, Miguel Hernández University, Alicante, Spain; Dermatology Department, Dr Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain https://orcid.org/0000-0002-6007-7320

DOI:

https://doi.org/10.2340/actadv.v106.adv-2026-0501

Keywords:

hidradenitis suppurativa, biological therapy, pregnancy, spontaneous abortion, congenital abnormalities

Downloads

Download data is not yet available.

References

Ghanshani R, Lee K, Crew AB, Shi VY, Hsiao JL. A guide to the management of hidradenitis suppurativa in pregnancy and lactation. Am J Clin Dermatol 2025; 26: 345–360. DOI: https://doi.org/10.1007/s40257-025-00935-x

Althagafi H, Spence AR, Czuzoj-Shulman N, Abenhaim HA. Effect of hidradenitis suppurativa on obstetric and neonatal outcomes. J Matern Fetal Neonatal Med 2022; 35: 8388–8393. DOI: https://doi.org/10.1080/14767058.2021.1974833

Fitzpatrick L, Hsiao J, Tannenbaum R, Strunk A, Garg A. Adverse pregnancy and maternal outcomes in women with hidradenitis suppurativa. J Am Acad Dermatol 2022; 86: 46–54. DOI: https://doi.org/10.1016/j.jaad.2021.06.023

Sánchez-García V, Hernández-Quiles R, de-Miguel-Balsa E, Giménez-Richarte Á, Ramos-Rincón JM, Belinchón-Romero I. Exposure to biologic therapy before and during pregnancy in patients with psoriasis: Systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2023; 37: 1971–1990. DOI: https://doi.org/10.1111/jdv.19238

Sánchez-García V, De-Miguel-Balsa E, Ramos-Rincón JM, Belinchón-Romero I. Safety of dupilumab therapy for atopic dermatitis during pregnanDupilumab Therapy for Atopic Dermatitis during Pregnancy: A systematic review and meta-analysis. Acta Derm Venereol 2025; 105: adv41307. DOI: https://doi.org/10.2340/actadv.v105.41307

Downloads

Additional Files

Published

2026-06-24

How to Cite

Sánchez-García, V., de-Miguel-Balsa, E., Ramos-Rincón, J.-M., & Belinchón-Romero, I. (2026). Reported Pregnancy Outcomes after Biologic Therapy Exposure in Hidradenitis Suppurativa: A Systematic Review of Published Cases. Acta Dermato-Venereologica, 106, adv–2026. https://doi.org/10.2340/actadv.v106.adv-2026-0501

Issue

Vol. 106 (2026)

Section

Research letter

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.

Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.

Crossref
Scopus
Google Scholar
Europe PMC